Authors

J Simon Bell

BPharm (Hons), PhD, Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Vic; NHMRC Cognitive Decline Partnership Centre, Hornsby Ku-ring-gai Hospital, Hornsby, NSW; NHMRC Centre for Research Excellence in Frailty and Healthy Ageing, Adelaide, SA; School of Public Health and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Vic; Sansom Institute, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA

Off-label prescribing in the midst of a pandemic: The case of hydroxychloroquine

There is currently no robust evidence to support prescribing hydroxychloroquine as a treatment or prophylaxis for COVID-19.


Current approaches to the pharmacological treatment of Alzheimer’s disease

Medications may be used in conjunction with non-pharmacological treatments to manage cognition, function and behaviour in people with Alzheimer’s disease.


Medication management of type 2 diabetes in residential aged care

This article reviews best practice medication management of type 2 diabetes mellitus in residential aged care facilities and highlights practical details for clinicians providing care for residents.